EI
AGRX

EAM Investors’s Agile Therapeutics AGRX Stock Holding History

EAM Investors’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-164
Closed -$819K – 310
2019
Q4 		$819K Buy
+164
New +$573K 0.18% 219
2016
Q2 		– Sell
-66
Closed -$822K – 390
2016
Q1 		$822K Sell
66
-3
-4% -$38.7K 0.13% 273
2015
Q4 		$1.34M Buy
69
+1
+1% +$15.8K 0.17% 223
2015
Q3 		$920K Hold
68
– – 0.15% 269
2015
Q2 		$1.17M Hold
68
– – 0.14% 285
2015
Q1 		$1.26M Buy
+68
New +$1.19M 0.15% 271

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return